NCT06925555: Brentuximab Vedotin Combined With R-CHP in Newly Diagnosed EBV+ DLBCL-NOS
- State
- Not started
- Phase
- Phase 2
- People
- 25 planned
- Started
- Sep 2025
- Primary completion
- 30 Dec 2028
- Arms
- BV+R-CHP Arm
- Results
- None posted
- 13 Apr 2025: Trial registered